Testicular cancer follow-up costs in Germany from 2000 to 2015
Advances in testicular cancer screening and therapy increased 10-year survival to 97% despite a rising incidence; eventually expanding the population of survivors requiring follow-up. We analyzed 10-year follow-up costs after testicular cancer treatment in Germany during 2000, 2008, and 2015.
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
22 April 2021
|
| In: |
Journal of cancer research and clinical oncology
Year: 2021, Jahrgang: 147, Heft: 8, Pages: 2249-2258 |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-021-03643-1 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00432-021-03643-1
|
| Verfasserangaben: | Thomas Michaeli, Julia Michaeli, Daniel Michaeli |
| Zusammenfassung: | Advances in testicular cancer screening and therapy increased 10-year survival to 97% despite a rising incidence; eventually expanding the population of survivors requiring follow-up. We analyzed 10-year follow-up costs after testicular cancer treatment in Germany during 2000, 2008, and 2015. |
|---|---|
| Beschreibung: | Gesehen am 25.01.2023 |
| Beschreibung: | Online Resource |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-021-03643-1 |